ArticleFrontiers in immunology2022

CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma.

Zhang-Wei Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.